1-4 of 4
Kentaro Narita
Close
Sort by
Journal Articles

Real-world applicability of the International Metabolic Prognostic Index in DLBCL: a validation cohort study

Daisuke Ikeda, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Kosei Matsue
Journal: Blood Advances
Blood Adv (2024) 8 (8): 1893–1897.
https://doi.org/10.1182/bloodadvances.2023012165
Published: 2024
Includes: Supplemental data
Journal Articles

Analysis of baseline circulating tumor cells integrated with PET/CT findings in transplant-ineligible multiple myeloma

Daisuke Ikeda, Toshiki Terao, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Kosei Matsue
Journal: Blood Advances
Blood Adv (2023) 8 (1): 37–46.
https://doi.org/10.1182/bloodadvances.2023011890
Published: 2023
Includes: Supplemental data
Journal Articles

Left ventricular diastolic function as a possible predictor of severe carfilzomib-induced cardiovascular events

Clinical Trials & Observations
Yoshiaki Abe, Tetsuya Kobayashi, Kentaro Narita, Hiroki Kobayashi, Akihiro Kitadate, Daisuke Miura, Masami Takeuchi, Kosei Matsue
Journal: Blood Advances
Blood Adv (2019) 3 (11): 1725–1728.
https://doi.org/10.1182/bloodadvances.2019000247
Published: 2019
Includes: Supplemental data
Journal Articles

Prognostic significance of bone marrow abnormalities in the appendicular skeleton of patients with multiple myeloma

Clinical Trials & Observations
Kosei Matsue, Hiroki Kobayashi, Yuya Matsue, Yoshiaki Abe, Kentaro Narita, Akihiro Kitadate, Masami Takeuchi
Journal: Blood Advances
Blood Adv (2018) 2 (9): 1032–1039.
https://doi.org/10.1182/bloodadvances.2017014720
Published: 2018
Includes: Supplemental data